Results 31 to 40 of about 734,472 (318)
The Journal of Headache and Pain, 2021 Background Patient-Reported Outcomes (PROs) have been developed to numerically quantify disability, impact and quality of life. They have been widely used in migraine clinical trials.
Alicia Alpuente +4 more
doaj +1 more source
The effect of placebo and neurophysiological involvements [PDF]
, 2004 Placebo and placebo effect are important issues related to the drug therapy for clinical and scientific meanings. The rates of placebo may get as many as 50% for analgesic drugs in headache. The high answer to placebo brings questions on pathophysiology
Galli, Federica +2 more
core +1 more source
Prolonged migraine aura: new insights from a prospective diary-aided study
The Journal of Headache and Pain, 2018 Background There is limited literature on prolonged aura (PA - defined as an aura including at least one symptom for > 1 h and 4 h (n = 14) with the the others (n = 193 and n = 202 respectively). Conclusion PAs are quite common.
Michele Viana +6 more
doaj +1 more source
Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches
Toxins, 2023 OnabotulinumtoxinA (BonT-A) reduces migraine frequency in a considerable portion of patients with migraine. So far, predictive characteristics of response are lacking. Here, we applied machine learning (ML) algorithms to identify clinical characteristics
Daniele Martinelli +7 more
doaj +1 more source
Structured education can improve primary-care management of headache: the first empirical evidence, from a controlled interventional study [PDF]
, 2016 Headache disorders are under-recognized and under-diagnosed. A principal factor in their suboptimal management is lack of headache-related training among health-care providers, especially in primary care.
Braschinsky, M +8 more
core +2 more sources
Pain and Therapy, 2020 Introduction Occipital nerve stimulation (ONS) is used to treat therapy-resistant chronic migraine. Clinical use has resulted in a wide intraindividual and interindividual variation of clinical efficacy.
Carl H. Göbel +8 more
doaj +1 more source
Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence
The Journal of Headache and Pain, 2023 Objective To explore and critically appraise the evidence supporting the role of estrogen withdrawal in menstrual migraine. Main body Menstrual migraine, impacting about 6% of reproductive-age women, manifests as migraine attacks closely related to the ...
Bianca Raffaelli +5 more
doaj +1 more source
P003. NSAIDs for symptomatic treatment of headache [PDF]
, 2015 Background and aims Clinical observations suggest that the use of non-steroidal anti-inflammatory drugs (NSAIDs) for symptomatic treatment of headache is not in line with recommendations by international guidelines [1].
Affaitati, Giannapia +8 more
core +1 more source
American Journal of Community Psychology, Volume 70, Issue 3-4, Page 265-277, December 2022., 2022 Abstract Community violence exposure is prevalent among urban and marginalized adolescents. Although there is strong evidence that community violence exposure is associated with negative consequences, prior studies and theories suggest that these associations may differ as a function of specific characteristics of exposure.
Sarah K. Pittman, Albert D. Farrell
wiley +1 more source
The Journal of Headache and Pain, 2022 Background and objectives The identification of predictors of response to antiCGRP mAbs could favor tailored therapies and personalized treatment plans.
Piero Barbanti +22 more
doaj +1 more source